Artelo Biosciences (ARTL) vs Valion Bio (VBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Valion Bio is the larger company by market cap ($2.0 million vs $1.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARTL | VBIO |
|---|---|---|
| Share price | $3.37 | $2.21 |
| Market cap | $1.85M | $1.96M |
| 1-day change | -1.17% | +0.91% |
| EPS (TTM) | $-136.26 | $-177.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $179.19 | $76.50 |
| 52-week low | $3.33 | $2.05 |
| Distance from 52-week high | -98.12% | -97.11% |
| Average volume | 480.72K | 1.46M |
| Shares outstanding | 547.77K | 887.59K |
| Employees | 7 | 52 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Artelo Biosciences
ARTL stock →Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
About Valion Bio
VBIO stock →Valion Bio, Inc. operates as a late-stage biopharmaceutical company.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 52 employees
ARTL vs VBIO FAQ
Which is bigger, Artelo Biosciences or Valion Bio?
Valion Bio (VBIO) is larger, with a market capitalization of $1.96M compared with $1.85M for Artelo Biosciences (ARTL).
Are Artelo Biosciences and Valion Bio in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Artelo Biosciences and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Valion Bio.